Clinical Analysis of a Risk-graded and Comprehensive Intervention for Early-childhood-caries
Clinical Analysis of Cariogram and Cariostat for Risk Assessment and Comprehensive Intervention of Early-childhood-caries
1 other identifier
interventional
480
1 country
1
Brief Summary
Cariogram and Cariostat will be used to assess the risk of caries in kindergarten children aged 3 years. Routine preventive measures will be taken for children at low risk of caries, and intensive intervention measures will be taken for children at medium and high risk. Routine measures will be taken for the control group. After one and two year, the prevalence of caries in the experimental group and the control group should be evaluated, and the cost-effectiveness evaluation will be conducted.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 4, 2021
CompletedFirst Submitted
Initial submission to the registry
December 12, 2021
CompletedFirst Posted
Study publicly available on registry
March 2, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2024
CompletedJuly 21, 2022
December 1, 2021
10 months
December 12, 2021
July 19, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Decay teeth,Missed teeth and filled teeth (DMFT) and the change between different time points.
The average value of the sum of the number of decayed teeth, the number of filled teeth, and the number of missed teeth due to caries.
Baseline, one year follow up and two year follow up.
Secondary Outcomes (1)
Caries prevalence and the change between different time points.
Baseline, one year follow up and two year follow up.
Study Arms (3)
Experimental subgroup of Cariostat
EXPERIMENTALUse Cariostat as the caries risk assessment tool to divide the children into different risk levels. Based on the results, children with low risk of caries will receive twice fluoride foam each year and oral hygiene guidance, children with middle or high risk of caries will receive forth fluoride applications each year, oral hygiene guidance and professional caries treatment.
Experimental subgroup of Cariogram
EXPERIMENTALUse Cariogram as the caries risk assessment tool to divide the children into different risk levels. Based on the results, children with low risk of caries will receive twice fluoride foam each year and oral hygiene guidance, children with middle or high risk of caries will receive forth fluoride applications each year, oral hygiene guidance and professional caries treatment.
Control group
PLACEBO COMPARATORUse Cariogram and as the caries risk assessment tool to divide the children into different risk levels. All children will receive routine prevention including wice fluoride foam each year and oral hygiene guidance.
Interventions
Children with low risk of caries will receive routine prevention including fluoride foam application twice a year and oral hygiene guidance. Children with middle or high risk of caries will receive fluoride varnish application twice a year and caries restorative treatment in addition to routine prevention. The risk-graded intervention is one kind of comprehensive prevention and treatment.
Routine prevention includes fluoride foam application twice a year and oral hygiene guidance.
Eligibility Criteria
You may qualify if:
- Junior kindergarten children who enter the kindergarten in September 2021 and can cooperate with the oral health examination.
- Parents of children fully understand the purpose of the study, cooperate with the questionnaire survey during the study, give informed consent and sign the informed consent form.
- The child has no serious systemic diseases, has not taken hormones and immunosuppressants within 6 months, and has no history of antibiotic use within 1 month,and is not allergic to fluoride.
You may not qualify if:
- Parents of children refuse to provide information about children's oral health or questionnaires.
- Children cannot cooperate with oral health examination.
- The child has a serious systemic disease that may affect the results of the study.
- Children who are allergic to fluoride.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, 10000, China
MeSH Terms
Interventions
Study Officials
- PRINCIPAL INVESTIGATOR
Menglin Cheng, Doctor
Beijing Friendship Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- After the data is entered, the analyst is analyzed under the premise of uninformed, and the packet is performed after all analyzes are completed.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 12, 2021
First Posted
March 2, 2022
Study Start
November 4, 2021
Primary Completion
August 31, 2022
Study Completion
August 31, 2024
Last Updated
July 21, 2022
Record last verified: 2021-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- When the two years follow up is completed and the result and conclusion of the study is published, the data will become available for half a year.
- Access Criteria
- The sharing criteria in this study is to the research leader who register study with key words of Caries Risk Assessment on the Clinical Trail.
The study protocol, statistical analysis plan, informed consent form and clinical study report are to be shared with other researchers.